Personal information

Verified email domains

stem cell biology, leukemia, hematology, single cell biology
United Kingdom

Activities

Employment (4)

University of York: York, North Yorkshire, GB

2022-10-01 to present | Professor (Biology)
Employment
Source: Self-asserted source
David Kent

University of York: York, North Yorkshire, GB

2019-09-01 to 2022-09-30 | Reader (Biology)
Employment
Source: Self-asserted source
David Kent

Wellcome / MRC Cambridge Stem Cell Institute: Cambridge, Cambridgeshire, GB

2015-08-01 to 2019-08-31 (Haematology)
Employment
Source: Self-asserted source
David Kent

University of Cambridge: Cambridge, GB

2009-10-01 to 2015-07-31 | Research Associate (Haematology)
Employment
Source: Self-asserted source
David Kent

Education and qualifications (2)

University of British Columbia: Vancouver, BC, CA

2003-09-01 to 2009-04-02 | PhD (Genetics)
Education
Source: Self-asserted source
David Kent

Western University: London, ON, CA

1999-09-01 to 2003-04-30 | Honors BSc (Genetics with English Literature)
Education
Source: Self-asserted source
David Kent

Professional activities (3)

European Hematology Association: The Hague, NL

2022-07-01 to present | Vice-Chair (Fellowships and Grants Committee)
Invited position
Source: Self-asserted source
David Kent

UKRI Medical Research Council: London, London, GB

2022 to 2026 | Board Member - MCMB Panel
Invited position
Source: Self-asserted source
David Kent

International Society for Experimental Hematology: Chicago, Illinois, US

2019-08-01 to 2022-08-31 | Board of Directors
Invited position
Source: Self-asserted source
David Kent

Funding (8)

Understanding the physical biology of adult blood stem cells

2017-05-01 to 2022-04-30 | Grant
European Research Council (Brussels, BE)
GRANT_NUMBER: 715371
Source: Self-asserted source
David Kent via DimensionsWizard

Identification of new blood cancer biomarkers

2016-05 to 2019-04 | Grant
Rosetrees Trust (Edgware, Middlesex, GB)
GRANT_NUMBER: A1162
Source: Self-asserted source
David Kent

Understanding fate choice in normal and malignant haematopoietic stem cells

2015-08-01 to 2020-08-01 | Grant
Bloodwise (London, GB)
GRANT_NUMBER:

BW-15008

Source: Self-asserted source
David Kent via DimensionsWizard

Cellular Characterization of Clonal Evolution in Myeloid Malignancies

2015-04 to 2018-03 | Grant
European Hematology Association (The Hague, NL)
Source: Self-asserted source
David Kent

Clonal Studies of the JAK2 V617F Mutation in Myeloproliferative Disorders

2009-10-01 to 2012-09-30 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER:

98557

GRANT_NUMBER: 98557
Source: Self-asserted source
David Kent via DimensionsWizard

50th Annual Meeting of the American Society of Hematology- San Francisco, CA New candidate regulators of hematopoietic stem cells identified from transcriptional comparisons of highly purified populations of longterm repopulating cells with markedly

The Molecular Characterization of Murine Hematopoietic Stem Cell Self-Renewal Divisions.

2007-04-01 to 2009-08-15 | Grant
Michael Smith Foundation for Health Research (n/a, CA)
GRANT_NUMBER:

10338

GRANT_NUMBER: 10338
Source: Self-asserted source
David Kent via DimensionsWizard
grade
Preferred source (of 2)‎

The molecular characterization of murine hematopoietic stem cell self-renewal divisions

2006-05-01 to 2009-04-30 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER:

80357

GRANT_NUMBER: 80357
Source: Self-asserted source
David Kent via DimensionsWizard

Peer review (32 reviews for 12 publications/grants)

Review activity for Developmental cell. (1)
Review activity for EMBO reports. (1)
Review activity for Experimental hematology. (4)
Review activity for Faculty Opinions (12)
Review activity for iScience. (1)
Review activity for Leukemia (1)
Review activity for Nature (1)
Review activity for Nature cancer. (1)
Review activity for Nature cell biology (1)
Review activity for Nature communications (6)
Review activity for Nature genetics. (1)
Review activity for Nature medicine. (2)